Biosynthetic Pathways of Ergot Alkaloids

被引:80
|
作者
Gerhards, Nina [1 ]
Neubauer, Lisa [2 ]
Tudzynski, Paul [2 ]
Li, Shu-Ming [1 ]
机构
[1] Univ Marburg, Inst Pharmazeut Biol & Biotechnol, D-35037 Marburg, Germany
[2] Univ Munster, Inst Biol & Biotechnol Pflanzen, D-48143 Munster, Germany
来源
TOXINS | 2014年 / 6卷 / 12期
关键词
ergot alkaloids; biosynthetic pathway; secondary metabolism; natural products; fungi; mycotoxins; DIMETHYLALLYL TRYPTOPHAN SYNTHASE; FUNGUS CLAVICEPS-PURPUREA; CHANOCLAVINE-I ALDEHYDE; ASPERGILLUS-FUMIGATUS; GENE-CLUSTER; PEPTIDE SYNTHETASE; FUMIGACLAVINE-C; LYSERGIC-ACID; BRANCH POINT; PURIFICATION;
D O I
10.3390/toxins6123281
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Ergot alkaloids are nitrogen-containing natural products belonging to indole alkaloids. The best known producers are fungi of the phylum Ascomycota, e.g., Claviceps, Epichloe, Penicillium and Aspergillus species. According to their structures, ergot alkaloids can be divided into three groups: clavines, lysergic acid amides and peptides (ergopeptines). All of them share the first biosynthetic steps, which lead to the formation of the tetracyclic ergoline ring system (except the simplest, tricyclic compound: chanoclavine). Different modifications on the ergoline ring by specific enzymes result in an abundance of bioactive natural products, which are used as pharmaceutical drugs or precursors thereof. From the 1950s through to recent years, most of the biosynthetic pathways have been elucidated. Gene clusters from several ergot alkaloid producers have been identified by genome mining and the functions of many of those genes have been demonstrated by knock-out experiments or biochemical investigations of the overproduced enzymes.
引用
收藏
页码:3281 / 3295
页数:15
相关论文
共 50 条